UPDATE : Thursday, December 5, 2019
상단여백
Doctors seem less eager to participate in ‘No-Japan’ campaign. Why?
The boycott of Japanese products has been intensifying over the past few mo...
by Lee Han-soo  |  2019-08-30 15:58
라인
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk
JW Pharmaceutical said more countries have recognized that its cholesterol-...
by Jeong Sae-im  |  2019-08-30 14:49
라인
'Mucosa healing essential for treating inflammatory bowel disease'
Takeda's Kynteles (Ingredient: Vedolizumab) is attempting a paradigm sh...
by Lee Han-soo  |  2019-08-30 12:42
라인
CAR-T therapy Kymriah, pie in the sky for Korean patients
Kymriah, Novartis’ new CAR-T (chimeric antigen receptor T-cell) treatment, ...
by Kim Yun-mi  |  2019-08-29 14:35
라인
Ildong’s subsidiary secures 1st anticancer drug pipeline
Idience, a subsidiary of Ildong Pharmaceutical, has acquired IDX-1197, an i...
by Lee Han-soo  |  2019-08-29 13:37
라인
Prosecutors raid Sillajen over alleged use of undisclosed information
The prosecution on Wednesday carried out simultaneous raids on Sillajen'...
by Lee Han-soo  |  2019-08-29 11:27
라인
Antidiabetic DPP-4 inhibitors mark double-digit sales growth
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, have ...
by Jeong Sae-im  |  2019-08-29 11:24
라인
Crystal Genomics' immunotherapy gets orphan drug status from US regulator
Crystal Genomics' CG-745, a molecular immunotherapy for pancreatic canc...
by Lee Han-soo  |  2019-08-28 17:44
라인
FDA OKs Boryung's P1 trial for immunotherapy candidate
Boryung Pharmaceutical said that the U.S. Food and Drug Administration has ...
by Lee Han-soo  |  2019-08-28 14:21
라인
Sales of new gastric acid blocker K-Cab top ￦10 billion
CJ HealthCare’s K-Cab Tab., the nation’s 30th novel drug, recorded over 10 ...
by Jeong Sae-im  |  2019-08-28 13:26
라인
Leo Pharma submits IND application for JW Pharmaceutical’s atopy treatment
JW Pharmaceutical said that Leo Pharma, a Denmark-based multinational pharm...
by Lee Han-soo  |  2019-08-28 13:24
라인
Pharmacists demand audit over Gliatilin’s insurance benefit
A pharmacists’ group demanded an audit against the Ministry of Health and W...
by Song Soo-youn  |  2019-08-27 16:01
라인
HLB to test rivoceranib+Lonsurf in colon cancer
HLB said it would test a combination therapy using rivoceranib with Lonsurf...
by Jeong Sae-im  |  2019-08-27 15:39
라인
Pharmaceutical sector’s job growth twice of all industries’ average
The pharmaceutical industry’s employment growth rate was eight times higher...
by Jeong Sae-im  |  2019-08-26 11:39
라인
Invossa still effective despite mislabeling, maker claims
Kolon Life Science said that U.S. orthopedic surgeons had published a resea...
by Lee Han-soo  |  2019-08-23 20:16
라인
Vivozon finishes P3 trial for nonnarcotic analgesics
Vivozon, a local biopharmaceutical company, said Friday that it has complet...
by Lee Han-soo  |  2019-08-23 16:03
라인
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma
HLB said Thursday it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im  |  2019-08-23 15:02
라인
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug
Haim Bio said that the Ministry of Food and Drug Safety has approved its in...
by Lee Han-soo  |  2019-08-23 13:53
라인
'Peptron's Parkinson's disease treatment blocks levodopa side effects'
Peptron said it has confirmed that PT320, a Parkinson's disease treatme...
by Lee Han-soo  |  2019-08-22 17:53
라인
‘Drug firm’s pick of doctor to attend conference overseas illegal’
Pharmaceutical companies’ support for physicians to attend academic confere...
by Kim Yun-mi  |  2019-08-22 15:45
-이전11121314151617181920-
Korea exports health insurance system to BahrainKorea exports health insurance system to Bahrain
여백
Most viewed
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top